U
Ulthera
Medical technology company developing non-invasive ultrasound-based devices for aesthetic medical procedures
About Ulthera
Ulthera, Inc. operates in the aesthetic medical device market, specializing in non-invasive skin lifting and tightening solutions. The company's flagship product, Ultherapy, utilizes ultrasound technology to stimulate collagen production, providing a non-surgical alternative for lifting the neck, chin, brow, and improving lines and wrinkles on the chest. Ulthera serves a diverse clientele, including dermatologists, plastic surgeons, and medical spas, targeting individuals seeking non-invasive cosmetic enhancements. The business model revolves around the sale of Ultherapy devices and consumables, as well as training and support services for medical professionals. Revenue is generated through direct sales, leasing options, and ongoing service agreements. Ulthera's market is characterized by a growing demand for non-surgical aesthetic treatments, driven by advancements in technology and increasing consumer preference for minimally invasive procedures.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2004
- Headquarters
- Mesa, United States
- Open positions
- None listed
- Dealroom signal
- 24.0/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Beauty, Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
- Investment activity
- 1 company, latest Mar 2014
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jun 2014 | $600M | $600M | Merz | — |
| SERIES C✓Equity / VC | Feb 2011 | $11M | $42M | NEA · Apposite Capital | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Ulthera is 0 monthly website visits, down 100% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
3i Group
NEA
Series B and later1 investor entered at this stage
Apposite Capital
Other known investors2 additional known investors
Merz
Vensana Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ulthera on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ulthera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.